Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D01OHD | ||||
| Former ID | DIB003006 | ||||
| Drug Name | AMXT-1501 | ||||
| Synonyms | Difluoromethylornithine + polyamine transport inhibitors (head and neck cancer), Aminex Therapeutics; Polyamine transport inhibitors + polyamine biosynthesis inhibitor (head and neck cancer), Aminex Therapeutics/MediQuest Therapeutics; MQT-1426 + DFMO (head and neck cancer), Aminex Therapeutics/MediQuest Therapeutics; Polyamine-based therapy (head and neck-squamous cell carcinoma), Aminex Therapeutics/MediQuest Therapeutics | ||||
| Indication | Head and neck cancer [ICD9: 140-149, 140-229; ICD10:C07-C14, C32-C33] | Investigative | [543400] | ||
| Company | MediQuest Therapeutics Inc | ||||
| Target and Pathway | |||||
| Target(s) | Ornithine decarboxylase | Target Info | Inhibitor | [543400] | |
| BioCyc Pathway | Putrescine biosynthesis I | ||||
| PANTHER Pathway | Ornithine degradation | ||||
| CCKR signaling map ST | |||||
| Pathway Interaction Database | Validated targets of C-MYC transcriptional activation | ||||
| PathWhiz Pathway | Spermidine and Spermine Biosynthesis | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
